Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment of acne is crucial to prevent scarring and psychological effects.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Plumbago zeylanica has valuable medicinal properties but needs sustainable cultivation methods.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

The research identified key molecules that help hair matrix and dermal papilla cells communicate and influence hair growth in cashmere goats.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Coffee and its by-products are promising for skin health benefits in cosmetics and help reduce environmental impact.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Drug repurposing shows promise for treating many medical conditions.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

The compounds tested could potentially treat hair loss and alopecia.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Companies agreed to stop false advertising about their products' health benefits.